Assessing the Impact and Risk Factors for Metabolic and Cardiovascular Complications in Adults with Noncommunicable Diseases in Ethiopia - Report - MDSpire

Assessing the Impact and Risk Factors for Metabolic and Cardiovascular Complications in Adults with Noncommunicable Diseases in Ethiopia

  • By

  • Alemneh Kabeta Daba

  • Alemu Tamiso Debiso

  • Frehiwot Atsbeha

  • Freshet Assefa

  • February 7, 2026

  • 0 min

Share

Clinical Report: Assessing the Impact and Risk Factors for Metabolic and Cardiovascular Complications in Adults with NCDs in Ethiopia

Overview

This study evaluates the burden and predictors of metabolic and cardiovascular complications among adults with noncommunicable diseases (NCDs) in Ethiopia. It highlights the increasing trend of NCD-related morbidity and mortality, emphasizing the need for targeted interventions.

Background

Noncommunicable diseases (NCDs) pose a significant health burden globally, particularly in low and middle-income countries like Ethiopia. The rising incidence of NCDs, including diabetes and hypertension, has led to increased mortality and disability-adjusted life years (DALYs). Understanding the risk factors for metabolic and cardiovascular complications is crucial for developing effective public health strategies and clinical guidelines.

Data Highlights

Replace '

No numerical data available in the provided text.

' with relevant statistics from the study.

Key Findings

  • In Ethiopia, NCDs contributed to approximately 550 deaths and 12,200 DALYs per 100,000 population in 2019.
  • 15% of individuals with NCD died while under medical care at tertiary hospitals.
  • The percentage contribution of NCDs to deaths increased from 8% to 35% over a decade.
  • Metabolic and cardiovascular complications are significant contributors to NCD-related mortality.
  • Context-specific evidence on risk factors for metabolic and cardiovascular complications is scarce but necessary for effective management.

Clinical Implications

Healthcare providers should prioritize the identification and management of metabolic and cardiovascular risks in patients with NCDs. Implementing comprehensive prevention and treatment strategies that incorporate both medical and behavioral interventions is essential for improving patient outcomes.

Conclusion

The findings underscore the urgent need for targeted interventions to address the rising burden of metabolic and cardiovascular complications in adults with NCDs in Ethiopia. Enhanced clinical guidelines and public health strategies are critical for effective management.

References

  1. European Journal of Preventive Cardiology, 2023 -- Addressing the Intersection of Diabetes and Cardiovascular Disease Prevention: Tackling Two Major Health Challenges
  2. European Journal of Preventive Cardiology, 2023 -- Variations in the Relationship Between Modifiable Lifestyle Risk Factors and New-Onset Cardiovascular Disease in Diabetic versus Non-Diabetic Individuals
  3. Clinical Research in Cardiology, 2023 -- Cardiovascular Event Risks in Metabolically Unhealthy Obese and Non-Obese Diabetic Patients: Insights from a Nationwide French Cohort Study
  4. The Journal of Clinical Endocrinology & Metabolism, 2023 -- Glycemic, Cardiorenal, and Weight Implications on Noninsulin Pharmacotherapy for the Management of Type 2 Diabetes
  5. 2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults - American College of Cardiology, 2025
  6. Oral Semaglutide and Cardiovascular Outcomes in High-Risk Type 2 Diabetes - PubMed, 2023
  7. 2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ASPC/NMA/PCNA/SGIM Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults - American College of Cardiology
  8. Oral Semaglutide and Cardiovascular Outcomes in High-Risk Type 2 Diabetes - PubMed

Original Source(s)

Related Content